Skip to main content
Figure 1 | Medical Gas Research

Figure 1

From: Open-label trial and randomized, double-blind, placebo-controlled, crossover trial of hydrogen-enriched water for mitochondrial and inflammatory myopathies

Figure 1

Temporal profiles of four parameters that demonstrate statistical significance by one-way repeated measures ANOVA in the open-label trial. Ratios of serum lactate/pyruvate (L/P) in 5 mitochondrial myopathies (MM) patients (A)and 4 progressive muscular dystrophy (PMD) patients (B). Note abnormally high L/P ratios in MM patients. (C)Fasting glucose in 4 PMD patients. (D)Serum MMP3 in 5 Polymyositis (PM)/Dermatomyositis (DM) patients. (E)Serum triglycerides in 4 PMD patients. Twelve weeks on HEW are indicated by a box in each panel. Means and SD are plotted. Statistically different values by the Bonferroni's multiple comparison test are indicated by 'a' and 'b' with *p < 0.05 and **p < 0.01. Bonferroni's test reveal no statistical difference between any two values in (D)and (E). Broken lines show a normal range of each parameter.

Back to article page

Medical Gas Research

ISSN: 2045-9912

Contact us